| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-09 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.0009 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |